Mr. Paul Duffy reports

AIML SUBSIDIARY NEURALCLOUD SIGNS NON-BINDING AGREEMENT WITH MOVESENSE TO PILOT AI-POWERED ECG AND HOLTER REPORTING

On Feb. 11, 2026, NeuralCloud Solutions Inc., a subsidiary of AI-ML Innovations Inc., entered into a non-binding agreement with Movesense, a global provider of medical-grade wearable sensing technology, to initiate a pilot program aimed at deploying AI-powered (artificial intelligence) ECG (electrocardiogram) and Holter reporting into real-world health care environments.

Under the agreement, the parties will collaborate on a pilot deployment, whereby NeuralCloud's software platforms are deployed through an existing Movesense client, within a third party health system and affiliated clinics. The pilot is designed to evaluate the use of NeuralCloud's MaxYield ECG signal processing platform and CardioYield visualization and reporting software to potentially increase ECG analysis capacity, improve reporting consistency and enhance clinical throughput.

The pilot is expected to serve as a foundation for a potential commercial rollout, subject to successful validation and mutually agreed upon next steps.

Under the collaboration, NeuralCloud's software platforms are being positioned as the analysis and reporting layer downstream of Movesense's medically certified wearable sensing hardware. This approach is designed to allow third party health care organizations and affiliated clinics to scale ECG screening reach, increase ECG review capacity and standardize reporting outputs without materially increasing clinical workload.

Through this collaboration, NeuralCloud continues to expand its presence in real-world outpatient, ambulatory and Holter-style monitoring environments by embedding AI-powered ECG analysis directly into existing clinical workflows. By pairing Movesense's wearable sensing hardware with NeuralCloud's software platforms, the solution is designed to increase ECG and Holter reporting capacity and throughput without requiring additional overhead or workflow changes. The integration of single-lead wearable devices with NeuralCloud's automated analysis further supports scalable deployment across outpatient and ambulatory care settings, where cost-efficiency, ease of integration and operational simplicity are essential.

"This expansion builds logically on the framework we announced in January," said Paul Duffy, executive chairman and chief executive officer at AI-ML. "By continuing to align NeuralCloud's software platforms with Movesense's device ecosystem, we are advancing toward practical, scalable solutions that address growing monitoring demands in ambulatory care."

"We see continued value in exploring how NeuralCloud's signal processing and reporting platforms can enhance the utility of our scalable ECG sensing technology," said Jussi Kaasinen, chief executive officer of Movesense. "This expanded collaboration allows us to further assess integration, performance and operational fit within health care workflows."

The pilot is to be conducted with a third party health care organization and one or more associated clinic sites, with a focus on operational validation, reporting performance, and workflow integration. Any future commercialization will be subject to definitive agreements, regulatory considerations and successful pilot outcomes.

About AI-ML Innovations Inc.

AI-ML Innovations is a global technology company pioneering the use of artificial intelligence and neural networks to transform digital health. The company's proprietary platforms leverage advanced signal processing and deep learning to convert complex biometric data into actionable clinical insights -- supporting earlier diagnosis, personalized treatment and more effective care.

AI-ML's shares trade on the Canadian Securities Exchange (symbol: AIML), the OTCQB Venture Market (symbol: AIMLF) and the Frankfurt Stock Exchange (symbol: 42FB).

We seek Safe Harbor.